Streetbeat News

Stock Prices

CSX

CSX Corporation reported Q3 earnings of 42 cents per share, meeting analyst consensus but marking a 19.23% decrease from last year. Quarterly sales were $3.57 billion, beating the analyst consensus of $3.55 billion but showing an 8.34% decrease from last year. Lower fuel prices, reduced intermodal storage revenue, a decline in export coal benchmark prices, and a decrease in intermodal volumes offset the effects of higher merchandise yields and coal volume growth. CSX ended the quarter with $1.36 billion in cash and equivalents, down by $598 million from last year. Total volume transported fell by 2% year-over-year to 1.55 million units. Revenue per unit fell by 6% to $2,305.

Portfolio Pulse from Ryan Gustafson

October 19, 2023 | 8:52 pm

SOXL

SQQQ

TMF

TQQQ

The ProShares UltraPro Short QQQ (SQQQ) and Direxion Daily 20+ Year Treasury Bull 3X Shares (TMF) ETFs have seen significant increases in net assets over the past week, adding $185.27 million and $50.70 million respectively. On the other hand, Direxion Daily Semiconductor Bull 3x Shares (SOXL) and ProShares UltraPro QQQ (TQQQ) have seen decreases in net assets, with SOXL down $254.56 million and TQQQ down $140.56 million.

Portfolio Pulse from Johnny Rice

October 19, 2023 | 8:50 pm

FLYU

NAIL

SPKY

UVIX

The 2x Long VIX Futures ETF (UVIX) and ConvexityShares Daily 1.5x SPIKES Futures ETF (SPKY) have seen significant increases over the past week, with UVIX up 24.77% and SPKY up 19.29%. On the other hand, Direxion Daily Homebuilders & Supplies Bull 3X Shares (NAIL) and MicroSectors Travel 3x Leveraged ETN (FLYU) have seen decreases, with NAIL down 18.39% and FLYU down 16.78%.

Portfolio Pulse from Johnny Rice

October 19, 2023 | 8:50 pm

MRK

A significant bullish stance has been taken on Merck & Co (NYSE:MRK) as evidenced by unusual options activity. The options scanner at Benzinga spotted 14 uncommon trades, with a split sentiment of 64% bullish and 35% bearish. The whales have been targeting a price range from $95.0 to $120.0 for Merck & Co over the last 3 months. The current price of MRK is down -1.53% at $100.43. Analysts have mixed opinions, with Cantor Fitzgerald and Truist Securities downgrading their actions but maintaining high price targets.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 8:46 pm

TSM

A significant amount of unusual options activity has been observed for Taiwan Semiconductor (NYSE:TSM), with a mix of bullish and bearish stances. Of the 35 unusual trades detected, 48% were bullish and 51% were bearish. The total amount for puts was $761,590 and for calls was $7,296,342. Whales have been targeting a price range from $70.0 to $120.0 for TSM over the last 3 months. The current price of TSM is up 3.4% at $92.65.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 8:46 pm

NLS

Nautilus has announced plans to change its corporate name to Bowflex effective from November 1. The company will also change its ticker from 'NLS' to 'BFX', according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:42 pm

GLD

QQQ

SPY

TLT

USO

The Israeli military has been given the 'green light' to enter Gaza, potentially leading to a ground invasion. This has caused a rise in the CBOE Volatility Index, a drop in the SPDR S&P 500 ETF Trust and the Invesco QQQ Trust, and an increase in the SPDR Gold Trust and the United States Oil Fund. The iShares 20+ Year Treasury ETF has also fallen. The US State Department has issued a global travel warning due to increased tensions.

Portfolio Pulse from Piero Cingari

October 19, 2023 | 8:37 pm

MDRR

Medalist Diversified REIT's board has approved the repurchase of an additional 200,000 shares of the company's common stock at a maximum price of $6.00 per share, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:36 pm

NVTA

Invitae (NYSE:NVTA), a medical genetics company, has appointed Dr. David Sholehvar as its new Chief Operating Officer, effective from November 13, 2023. Dr. Sholehvar has a 25-year track record in healthcare business leadership, having held roles at NeoGenomics Inc., Dynex Technologies, Quest Diagnostics, and Johnson & Johnson. As part of his hiring, Invitae is granting 850,000 restricted stock units to Dr. Sholehvar under its 2015 Stock Incentive Plan.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:35 pm

WAL

Western Alliance (NYSE:WAL) reported Q3 earnings of $1.97 per share, beating the analyst consensus estimate of $1.90 by 3.68%. However, this is a 18.6% decrease from last year's earnings. The company also reported quarterly sales of $716.20 million, beating the analyst consensus estimate of $676.46 million by 5.87%, and marking a 7.88% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:34 pm